SAN DIEGO, Jan. 4, 2021 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, will present at the 39th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 11th at 12:40 p.m. PST/ 3:40 p.m. EST. Charles M. Baum, M.D., Ph.D., Mirati’s President and Chief Executive Officer will present at the […]
